Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.
about
The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.Advances in the prognostication and management of advanced MDS in children.-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.Advancing stem cell therapy from bench to bedside: lessons from drug therapiesIndications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina.Salvage allogeneic stem cell transplantation in patients with pediatric myelodysplastic syndrome and myeloproliferative neoplasms.Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database.Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
P2860
Q37602425-86EFB0AC-3404-42F0-A178-38CBA027CACBQ37873542-5A025482-A163-4B70-99F2-2322808474D2Q38226741-B9CD7257-CD1B-4CD5-B6CC-A44EBC45CC62Q38245564-1CC52E98-C69B-46AC-B890-FE07FD4FE186Q38387292-523F7037-D364-4093-A308-37844DA73A2FQ43737380-50E33ACA-2E9C-411F-8D6B-E93D912D1A9AQ44734561-FB07283E-D964-4386-9B5E-EF00FB471E0DQ44756831-C992F450-86D9-4E3C-8397-1E6AF3CCE348Q44953364-611D7C59-9A7B-4077-8ADA-89BA5E006949Q52613271-412F135F-65EE-4583-8579-0FA6C43CA078Q52688938-F215AA13-B731-4B9D-A155-837C2F2038F0Q53268701-68FCBB21-A762-4C5E-8FA1-1A3D7DE1F8B2
P2860
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Analysis of risk factors influ ...... ed cord blood transplantation.
@ast
Analysis of risk factors influ ...... ed cord blood transplantation.
@en
type
label
Analysis of risk factors influ ...... ed cord blood transplantation.
@ast
Analysis of risk factors influ ...... ed cord blood transplantation.
@en
prefLabel
Analysis of risk factors influ ...... ed cord blood transplantation.
@ast
Analysis of risk factors influ ...... ed cord blood transplantation.
@en
P2093
P2860
P356
P1433
P1476
Analysis of risk factors influ ...... ted cord blood transplantation
@en
P2093
A B M Madureira
A Woolfrey
C M Sales-Bonfim
C Niemeyer
Center of International Blood and Marrow Transplant Registry
E Gluckman
Eurocord-European Blood and Marrow Transplant Group
European Working Group on childhood MDS
F Locatelli
P2860
P2888
P304
P356
10.1038/LEU.2010.285
P577
2010-12-07T00:00:00Z